Publication: Effects of potent nitric oxide-guanylyl cyclase activator and phosphodiesterase-5 inhibitor on cognitive deficits in diabetic rats
| dc.contributor.authors | Utkan, T.; Ozer, C.; Gacar, N.; Aricioglu, F. | |
| dc.date.accessioned | 2022-03-12T16:13:54Z | |
| dc.date.accessioned | 2026-01-11T10:34:51Z | |
| dc.date.available | 2022-03-12T16:13:54Z | |
| dc.date.issued | 2012 | |
| dc.identifier.doi | 10.1016/S0924-977X(12)70301-2 | |
| dc.identifier.issn | 0924-977X | |
| dc.identifier.uri | https://hdl.handle.net/11424/225138 | |
| dc.identifier.wos | WOS:000317948600192 | |
| dc.language.iso | eng | |
| dc.publisher | ELSEVIER SCIENCE BV | |
| dc.relation.ispartof | EUROPEAN NEUROPSYCHOPHARMACOLOGY | |
| dc.rights | info:eu-repo/semantics/closedAccess | |
| dc.title | Effects of potent nitric oxide-guanylyl cyclase activator and phosphodiesterase-5 inhibitor on cognitive deficits in diabetic rats | |
| dc.type | conferenceObject | |
| dspace.entity.type | Publication | |
| oaire.citation.endPage | S207 | |
| oaire.citation.startPage | S207 | |
| oaire.citation.title | EUROPEAN NEUROPSYCHOPHARMACOLOGY | |
| oaire.citation.volume | 22 |
